Elucidating the cellular determinants of targeted membrane protein degradation by lysosome-targeting chimeras
Science · 20.10.2023 · 382 (6668)
DOI: 10.1126/science.adf6249 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 20.10.2023. Verfasst von Green Ahn und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Stanford University, Stanford, CA 94305, USA. Hauptthemen laut MEDLINE: Lysosomes, Membrane Proteins, Proteolysis, Receptor, IGF Type 2. Die Arbeit wurde bisher 204-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Targeted protein degradation can provide advantages over inhibition approaches in the development of therapeutic strategies. Lysosome-targeting chimeras (LYTACs) harness receptors, such as the cation-independent mannose 6–phosphate receptor (CI-M6PR), to direct extracellular proteins to lysosomes. In this work, we used a genome-wide CRISPR knockout approach to identify modulators of LYTAC-mediated membrane protein degradation in human cells. We found that disrupting retromer genes improved target degradation by reducing LYTAC recycling to the plasma membrane. Neddylated cullin-3 facilitated LYTAC-complex lysosomal maturation and was a predictive marker for LYTAC efficacy. A substantial fraction of cell surface CI-M6PR remains occupied by endogenous M6P-modified glycoproteins. Thus, inhibition of M6P biosynthesis increased the internalization of LYTAC-target complexes. Our findings inform design strategies for next-generation LYTACs and elucidate aspects of cell surface receptor occupancy and trafficking.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Stanford University, Stanford, CA 94305, USA.
- Sarafan ChEM-H, Stanford University, Stanford, CA 94305, USA.
- Department of Genetics, Stanford University, Stanford, CA 94305, USA.
- Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
- Howard Hughes Medical Institute, Stanford University, Stanford, CA 94305, USA.
ORCID-Profile: Green Ahn, Nicholas M Riley, Roarke A Kamber, Salvador Moncayo von Hase, Michael C Bassik, Steven M Banik, Carolyn R Bertozzi
Förderung
- NIGMS NIH HHS
- NCI NIH HHS
Zitieren
APA
Ahn, G., Riley, N. M., Kamber, R. A., Wisnovsky, S., Moncayo von Hase, S., Bassik, M. C., Banik, S. M., & Bertozzi, C. R. (2023). Elucidating the cellular determinants of targeted membrane protein degradation by lysosome-targeting chimeras. Science, 382(6668). https://doi.org/10.1126/science.adf6249
Vancouver
Ahn G, Riley NM, Kamber RA, Wisnovsky S, Moncayo von Hase S, Bassik MC, et al. Elucidating the cellular determinants of targeted membrane protein degradation by lysosome-targeting chimeras. Science. 2023;382(6668). doi:10.1126/science.adf6249
BibTeX
@article{Ahn2023,
author = {Ahn, Green and Riley, Nicholas M and Kamber, Roarke A and Wisnovsky, Simon and Moncayo von Hase, Salvador and Bassik, Michael C and Banik, Steven M and Bertozzi, Carolyn R},
title = {Elucidating the cellular determinants of targeted membrane protein degradation by lysosome-targeting chimeras},
journal = {Science},
year = {2023},
volume = {382},
number = {6668},
doi = {10.1126/science.adf6249}
}
EUVIMED